Send feedback

SUN2 p.Leu89Arg

c.266T>G · rs35496634 · VCV1167140

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.0712 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 11.1%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Emery-Dreifuss muscular dystrophy

Computational evidence

Protein change
AlphaMissense0.0712likely benign
REVEL0.079moderately benign-leaning
SaProtLLR -6.21tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.8GERP 1.8, phastCons 1
Regional constrainto/e 0.94unconstrained · MANE · 12 kb · p 0.11 · regional, not allelic
Overall
CADD20.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 11.1% European (non-Finnish) · 130,400/1,179,126 alleles
Filtering AF 11% ClinGen BA1/BS1 input FAF95, joint · FAF99 11%
Overall 9.54% 153,866/1,613,000 alleles · common exomes 142,245/1,460,736 · genomes 11,621/152,264 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 23.2% 4
Finnishnot grpmax-eligible 14.2% 7
European (non-Finnish)grpmax 11.1% 9
Ashkenazi Jewishnot grpmax-eligible 8.65% 12
Remaining individualsnot grpmax-eligible 8.54% 12
Middle Eastern 7.21% 14
Admixed American 5.01% 20
African / African-American 1.76% 57
South Asian 1.63% 61
East Asian 0.0245% 4,077

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SUN2
Protein
p.Leu89Arg
Coding
c.266T>G
MANE Select
NM_015374
dbSNP
rs35496634
Type
single nucleotide variant
Location
chr22:38751230 (GRCh38)
Gene constraint
LOEUF 0.756 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 68.48 · 9 PDB
Residue 89
a UniProt-annotated variant site (in); the 'lmna-binding' region
Full SUN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Emery-Dreifuss muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Emery-Dreifuss muscular dystrophy (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Childhood
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sun2-p-leu89arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown